Right now, Taylor Sundby, MD 🧬 is sharing his research on #neurofibromatosis at the 5th Annual Children's Cancer Foundation's Research Symposium. Local #pediatriccancer researchers will speak LIVE all day today - Join now: huddlearea.com/ccfsymposium

We are excited to see this work published and hope it will help improve our understanding and clinical management of #RareCancers such as bone and soft-tissue #Sarcoma. Please get in touch if you are interested in collaborating with us!

Super excited to share this publication - a 7+ year journey of discovery, started when I was a post-doc and driven home by the exceptional Dr. Biniam Adane in the Stegmaier lab Dana-Farber/Boston Children's. Loss of STAG2 rewires Ewing Sarcoma transcriptional programs: authors.elsevier.com/c/1dEna5TA51Vy…

Upcoming phase III study of selumetinib in adult patients with NF1 and symptomatic inoperable plexiform neurofibromas #nfcon2021 NCI CCR Pediatric Oncology Branch Children's Tumor Fdn #RareDisease #NCIDTC NCI Treatment

This is Raylin. She has #DIPG, and wants to meet JoJo Siwa . I believe in the power of Twitter! Let’s do this! #buggysdreamcometrue

Every single damn day there is another child like Francesca. A child who dies of cancer. A family who found out their child's cancer returned. A family that just learned their baby has cancer. We aren't doing enough. It makes me so angry we don't treat this like an emergency.

We're making great progress on National Cancer Institute’s Childhood #CancerData Initiative (CCDI). An important part of the CCDI is the National #ChildhoodCancer Registry (NCCR), which uses 23 registries to identify and follow children and AYAs with cancer in the U.S. cancer.gov/research/areas…

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium ascopubs.org/doi/full/10.12… Excited to report on the results of many years of work and which will impact therapy for patients with rhabdomyosarcoma.

If you treat cancer and have 5 minutes to spare, read about my little boy💔 #JCO ASCO Publications #btsm My Beautiful Boy | Journal of Clinical Oncology ascopubs.org/doi/full/10.12…

Our Natural History Study of Rare Solid Tumors is enrolling people with rare solid tumors to study them over time in hopes of developing new treatments. You can easily submit your information through our #MyPART site, and our staff will reach out to you: bit.ly/3k0h48e

The Physician-Scientist Early Investigator Program is an exciting training opportunity intended for early career physicians dedicated to laboratory bench-to-bedside or clinic-based research. Apply now for the next academic year bit.ly/3jx0xZa #CCRJobs #CancerResearch

#ChildhoodCancerAwarenessMonth Looking for #clinicaltrials for neurofibromatosis type 1 ( #NF1 )? We've done the search for you at bit.ly/3iCwteX NCI CCR Pediatric Oncology Branch

JUST ANNOUNCED: NCI's Childhood Cancer Data Initiative (#CCDI) launches the Molecular Characterization Initiative for #ChildhoodCancer research to foster data sharing through comprehensive cancer analysis. Learn more: go.usa.gov/xzy3k #Data4ChildhoodCancer NCI Center for Cancer Research

Children and AYAs with newly diagnosed soft tissue sarcomas who are receiving care at a Children’s Oncology Group member site are now eligible to enroll in the CCDI Molecular Characterization Initiative. Find out more. cancer.gov/research/areas… #Data4ChildhoodCancer

.National Cancer Institute’s Childhood Cancer Data Initiative has grown since its launch in 2019. Read about the initiative’s activities, successes, and priorities for the future in the most recent issue of Journal of Clinical Oncology. #Data4ChildhoodCancer buff.ly/3Pspian

19/ Please visit medrxiv.org/cgi/content/sh… for the full story and list of amazing contributors like Béga Murray Brian Van Tine and many other twitter-less collaborators!